These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 29032954)

  • 1. Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage.
    Charytan DM; Skali H; Shah NR; Veeranna V; Cheezum MK; Taqueti VR; Kato T; Bibbo CR; Hainer J; Dorbala S; Blankstein R; Di Carli MF
    Kidney Int; 2018 Feb; 93(2):501-509. PubMed ID: 29032954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary vascular dysfunction and prognosis in patients with chronic kidney disease.
    Murthy VL; Naya M; Foster CR; Hainer J; Gaber M; Dorbala S; Charytan DM; Blankstein R; Di Carli MF
    JACC Cardiovasc Imaging; 2012 Oct; 5(10):1025-34. PubMed ID: 23058070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of moderate chronic kidney disease with insufficient improvement of fractional flow reserve after stent implantation.
    Sakoda K; Tanaka N; Hokama Y; Hoshino K; Murata N; Yamashita J; Yamashina A
    Catheter Cardiovasc Interv; 2016 Aug; 88(2):E38-44. PubMed ID: 26489880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.
    Gregg LP; Adams-Huet B; Li X; Colbert G; Jain N; de Lemos JA; Hedayati SS
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelium-Dependent and -Independent Vascular Function in Advanced Chronic Kidney Disease.
    Kopel T; Kaufman JS; Hamburg N; Sampalis JS; Vita JA; Dember LM
    Clin J Am Soc Nephrol; 2017 Oct; 12(10):1588-1594. PubMed ID: 28784655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased basal myocardial perfusion in patients with chronic kidney disease without symptomatic coronary artery disease.
    Koivuviita N; Tertti R; Järvisalo M; Pietilä M; Hannukainen J; Sundell J; Nuutila P; Knuuti J; Metsärinne K
    Nephrol Dial Transplant; 2009 Sep; 24(9):2773-9. PubMed ID: 19369689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary microvascular function in early chronic kidney disease.
    Charytan DM; Shelbert HR; Di Carli MF
    Circ Cardiovasc Imaging; 2010 Nov; 3(6):663-71. PubMed ID: 20851872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal function and risk stratification of diabetic and nondiabetic patients undergoing evaluation for coronary artery disease.
    Hakeem A; Bhatti S; Karmali KN; Dillie KS; Cook JR; Xu J; Samad Z; Chang SM
    JACC Cardiovasc Imaging; 2010 Jul; 3(7):734-45. PubMed ID: 20633852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractional Flow Reserve Evaluation and Chronic Kidney Disease: Analysis From a Multicenter Italian Registry (the FREAK Study).
    Tebaldi M; Biscaglia S; Fineschi M; Manari A; Menozzi M; Secco GG; Di Lorenzo E; D'Ascenzo F; Fabbian F; Tumscitz C; Ferrari R; Campo G
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):555-562. PubMed ID: 26717890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive characterization of myocardial and vascular phenotype in pediatric chronic kidney disease using cardiovascular magnetic resonance imaging.
    Cheang MH; Barber NJ; Khushnood A; Hauser JA; Kowalik GT; Steeden JA; Quail MA; Tullus K; Hothi D; Muthurangu V
    J Cardiovasc Magn Reson; 2018 Mar; 20(1):24. PubMed ID: 29609642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decline in 20-year mortality after myocardial infarction in patients with chronic kidney disease: evolution from the prethrombolysis to the percutaneous coronary intervention era.
    Nauta ST; van Domburg RT; Nuis RJ; Akkerhuis M; Deckers JW
    Kidney Int; 2013 Aug; 84(2):353-8. PubMed ID: 23486524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echocardiography to predict adverse cardiac and vascular events in patients with severe chronic kidney disease (stage 4): a prospective study.
    Lesaffre F; Wynckel A; Nazeyrollas P; Rieu P; Metz D
    Arch Cardiovasc Dis; 2013 Apr; 106(4):220-7. PubMed ID: 23706368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve.
    Murthy VL; Naya M; Foster CR; Hainer J; Gaber M; Di Carli G; Blankstein R; Dorbala S; Sitek A; Pencina MJ; Di Carli MF
    Circulation; 2011 Nov; 124(20):2215-24. PubMed ID: 22007073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of predictability of future cardiovascular events between chronic kidney disease (CKD) stage based on CKD epidemiology collaboration equation and that based on modification of diet in renal disease equation in the Japanese general population--Iwate KENCO Study.
    Ohsawa M; Tanno K; Itai K; Turin TC; Okamura T; Ogawa A; Ogasawara K; Fujioka T; Onoda T; Yoshida Y; Omama S; Ishibashi Y; Nakamura M; Makita S; Tanaka F; Kuribayashi T; Koyama T; Sakata K; Okayama A
    Circ J; 2013; 77(5):1315-25. PubMed ID: 23428718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparities in the Estimation of Glomerular Filtration Rate According to Cockcroft-Gault, Modification of Diet in Renal Disease-4, and Chronic Kidney Disease Epidemiology Collaboration Equations and Relation With Outcomes in Patients With Acute Coronary Syndrome.
    Rivera-Caravaca JM; Ruiz-Nodar JM; Tello-Montoliu A; Esteve-Pastor MA; Quintana-Giner M; Véliz-Martínez A; Orenes-Piñero E; Romero-Aniorte AI; Vicente-Ibarra N; Pernias-Escrig V; Carrillo-Alemán L; Candela-Sánchez E; Hortelano I; Villamía B; Sandín-Rollán M; Nuñez-Martínez L; Valdés M; Marín F
    J Am Heart Assoc; 2018 Apr; 7(9):. PubMed ID: 29680822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of fractional phosphate excretion on the relation of FGF23 with outcome in CKD patients.
    Bech AP; Bouma-de Krijger A; van Zuilen AD; Bots ML; van den Brand JA; Blankestijn PJ; Wetzels JF; Vervloet MG
    J Nephrol; 2015 Aug; 28(4):477-84. PubMed ID: 25700931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal function estimation and Cockroft-Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart 'OMics' in AGEing (HOMAGE) and the high-risk myocardial infarction database initiatives.
    Ferreira JP; Girerd N; Pellicori P; Duarte K; Girerd S; Pfeffer MA; McMurray JJ; Pitt B; Dickstein K; Jacobs L; Staessen JA; Butler J; Latini R; Masson S; Mebazaa A; Rocca HP; Delles C; Heymans S; Sattar N; Jukema JW; Cleland JG; Zannad F; Rossignol P;
    BMC Med; 2016 Nov; 14(1):181. PubMed ID: 27829460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Risk Prediction With the CKD-EPI and MDRD Equations in Non-ST-Segment Elevation Acute Coronary Syndrome.
    Flores-Blanco PJ; López-Cuenca Á; Januzzi JL; Marín F; Sánchez-Martínez M; Quintana-Giner M; Romero-Aniorte AI; Valdés M; Manzano-Fernández S
    Clin Cardiol; 2016 Sep; 39(9):507-15. PubMed ID: 27249221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of micro- and macrovascular biomarkers on cardiovascular outcome in chronic kidney disease: a prospective cohort study.
    Cseprekál O; Egresits J; Tabák Á; Nemcsik J; Járai Z; Babos L; Fodor E; Farkas K; Godina G; Kárpáthi KI; Kerkovits L; Marton A; Nemcsik-Bencze Z; Németh Z; Sallai L; Kiss I; Tislér A
    J Hum Hypertens; 2016 Jul; 30(7):449-55. PubMed ID: 26424101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.